Mint Tower Capital Management B.V. Intercept Pharmaceuticals, Inc. Put Options Transaction History

Mint Tower Capital Management B.V.

  • $314 Million
  • Q2 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$9.99 - $18.71 $149,850 - $280,650
15,000 New
15,000 $278,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Mint Tower Capital Management B.V. Portfolio

Follow Mint Tower Capital Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mint Tower Capital Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email